Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis*

K. B. Gordon; M. Lebwohl; K. A. Papp; H. Bachelez; J. J. Wu; R. G. Langley; A. Blauvelt; B. Kaplan; M. Shah; Y. Zhao; R. Sinvhal; K. Reich

doi:10.1111/bjd.20818

Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis*

K. B. Gordon, M. Lebwohl, K. A. Papp, H. Bachelez, J. J. Wu, R. G. Langley, A. Blauvelt, B. Kaplan, M. Shah, Y. Zhao, R. Sinvhal, K. Reich

Research output: Contribution to journal › Article › peer-review

62 Citations (Scopus)

Original language	English
Pages (from-to)	466-475
Number of pages	10
Journal	British Journal of Dermatology
Volume	186
Issue number	3
DOIs	https://doi.org/10.1111/bjd.20818
Publication status	Published - Mar 2022
Externally published	Yes

ASJC Scopus Subject Areas

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bjd.20818

Cite this

@article{ec71c1b8e0bb45859a15b3e1299940ac,

title = "Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis*",

author = "Gordon, {K. B.} and M. Lebwohl and Papp, {K. A.} and H. Bachelez and Wu, {J. J.} and Langley, {R. G.} and A. Blauvelt and B. Kaplan and M. Shah and Y. Zhao and R. Sinvhal and K. Reich",

note = "Publisher Copyright: {\textcopyright} 2021 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists",

year = "2022",

month = mar,

doi = "10.1111/bjd.20818",

language = "English",

volume = "186",

pages = "466--475",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis*

AU - Gordon, K. B.

AU - Lebwohl, M.

AU - Papp, K. A.

AU - Bachelez, H.

AU - Wu, J. J.

AU - Langley, R. G.

AU - Blauvelt, A.

AU - Kaplan, B.

AU - Shah, M.

AU - Zhao, Y.

AU - Sinvhal, R.

AU - Reich, K.

PY - 2022/3

Y1 - 2022/3

UR - http://www.scopus.com/inward/record.url?scp=85119997467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85119997467&partnerID=8YFLogxK

U2 - 10.1111/bjd.20818

DO - 10.1111/bjd.20818

M3 - Article

C2 - 34652810

AN - SCOPUS:85119997467

SN - 0007-0963

VL - 186

SP - 466

EP - 475

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 3

ER -

Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis*

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this